B

Brain+ A/S
CSE:BRAINP

Watchlist Manager
Brain+ A/S
CSE:BRAINP
Watchlist
Price: 0.0942 DKK 6.08% Market Closed
Market Cap: 20m DKK
Have any thoughts about
Brain+ A/S?
Write Note

Brain+ A/S
Other Long-Term Assets

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Brain+ A/S
Other Long-Term Assets Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Other Long-Term Assets CAGR 3Y CAGR 5Y CAGR 10Y
B
Brain+ A/S
CSE:BRAINP
Other Long-Term Assets
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
N
NNIT A/S
CSE:NNIT
Other Long-Term Assets
kr78m
CAGR 3-Years
35%
CAGR 5-Years
15%
CAGR 10-Years
N/A
M
Monsenso A/S
CSE:MONSO
Other Long-Term Assets
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Brain+ A/S
Glance View

Market Cap
20m DKK
Industry
Health Care

Brain+ A/S is engaged in the developing of medical software to detect and treat the cognitive symptoms of dementia and the most common cause of dementia, namely Alzheimer's disease. The firm focuses on the development of digital treatment for dementia and Alzheimer’s disease by digital therapeutics. The Company’s main activities include the development of Cognitive Stimulation Therapy for the treatment of dementia, Computerized Cognitive Training for the treatment of earlier stages of Alzheimer’s and Starry Night memory test for early detection and monitoring of Alzheimer’s. The company offers a product called Digital CST assistant giving access to Cognitive Stimulation Therapy sessions, available in Danish.

BRAINP Intrinsic Value
0.0478 DKK
Overvaluation 49%
Intrinsic Value
Price
B

See Also

Back to Top